TFR Capital LLC. Purchases 1,214 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

TFR Capital LLC. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,650 shares of the healthcare conglomerate's stock after purchasing an additional 1,214 shares during the quarter. UnitedHealth Group accounts for 1.4% of TFR Capital LLC.'s investment portfolio, making the stock its 16th largest position. TFR Capital LLC.'s holdings in UnitedHealth Group were worth $3,483,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. IAG Wealth Partners LLC bought a new position in shares of UnitedHealth Group during the 1st quarter valued at about $42,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in UnitedHealth Group during the fourth quarter valued at $41,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

NYSE UNH traded up $4.30 during trading on Friday, hitting $303.81. 9,789,082 shares of the company's stock traded hands, compared to its average volume of 7,703,876. The stock has a market capitalization of $275.60 billion, a price-to-earnings ratio of 12.72, a PEG ratio of 1.46 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The business has a 50 day moving average of $314.52 and a 200-day moving average of $440.43. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the prior year, the business posted $6.91 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.91%. UnitedHealth Group's dividend payout ratio is 37.02%.

Insider Buying and Selling

In other news, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.28% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of analyst reports. Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Morgan Stanley cut their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, TD Securities reiterated a "hold" rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $415.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.